KRASG12C mutation in metastatic colorectal cancer: a new target

被引：1
|
作者：
Ibrahim, Rebecca [1 ]
Saleh, Khalil [1 ]
Chahine, Claude [1 ]
Khoury, Rita [1 ]
Khalife, Nadine [2 ]
Lecesne, Axel [1 ]
机构：
[1] Gustave Roussy Canc Campus, Int Dept, F-94800 Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Head & Neck Oncol, F-94800 Villejuif, France
来源：
FUTURE ONCOLOGY | 2023年 / 19卷 / 24期
关键词：
adagrasib; colorectal cancer; KRAS(G12C) mutation; RAS; sotorasib; INHIBITORS; SOTORASIB;
D O I：
10.2217/fon-2023-0223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1641 / 1643
页数：3
相关论文
共 50 条
  • [21] Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor
    Wijeratne, Aruna
    Xiao, Junpeng
    Reutter, Christopher
    Furness, Kelly W.
    Leon, Rebecca
    Zia-Ebrahimi, Mohammad
    Cavitt, Rachel N.
    Strelow, John M.
    Van Horn, Robert D.
    Peng, Sheng-Bin
    Barda, David A.
    Engler, Thomas A.
    Chalmers, Michael J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (06): : 557 - 562
  • [22] Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
    Zhang, Shannon S.
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 115 - 122
  • [23] An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations
    Strohbehn, Garth W.
    Sankar, Kamya
    Qin, Angel
    Kalemkerian, Gregory P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (14) : 1569 - 1575
  • [24] Sotorasib inhibits ubiquitination degradation of TXNIP and suppresses glucose metabolism in KRASG12C mutant bladder cancer
    Zhang, Zhi-Rong
    Liu, Min-Qi
    Ji, Yang
    Xiao, Di
    Wang, Wei-Fan
    Zhou, Xiao-Chen
    Wang, Ling-Hui
    Li, Duo
    Zou, Hui
    Yang, Xiao-Ping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11):
  • [25] Expanding the KRASG12C Inhibitor Class: What Do We Need Next?
    Norman, Aurora
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (07) : 844 - 846
  • [26] KRasG12C inhibitors in clinical trials: a short historical perspective
    Goebel, Lisa
    Mueller, Matthias P.
    Goody, Roger S.
    Rauh, Daniel
    RSC MEDICINAL CHEMISTRY, 2020, 11 (07): : 760 - 770
  • [27] A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished
    Ning, Wenjuan
    Yang, Zhang
    Kocher, Gregor J.
    Dorn, Patrick
    Peng, Ren-Wang
    CANCERS, 2022, 14 (02)
  • [28] Drugging the undruggable: a computational chemist's view of KRASG12C
    Bodnarchuk, Michael S.
    Cassar, Doyle J.
    Kettle, Jason G.
    Robb, Graeme
    Ward, Richard A.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (04): : 609 - 614
  • [29] Covalent inhibitors of the GTPase KRASG12C: a review of the patent literature
    Kettle, Jason G.
    Cassar, Doyle J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (02) : 103 - 120
  • [30] WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer
    Yamamoto, Gaku
    Tanaka, Kosuke
    Kamata, Ryo
    Saito, Hitoshi
    Yamamori-Morita, Tomoko
    Nakao, Takehiro
    Liu, Jie
    Mori, Shunta
    Yagishita, Shigehiro
    Hamada, Akinobu
    Shinno, Yuki
    Yoshida, Tatsuya
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Watanabe, Shun-Ichi
    Yatabe, Yasushi
    Kitai, Hidenori
    Konno, Satoshi
    Kobayashi, Susumu S.
    Ohashi, Akihiro
    CANCER LETTERS, 2025, 611
12345